303 related articles for article (PubMed ID: 30236776)
1. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
2. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
[TBL] [Abstract][Full Text] [Related]
3. Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial.
Le Compte CG; Lu SE; Ani J; McDougall J; Walters ST; Toppmeyer D; Boyce TW; Stroup A; Paddock L; Grumet S; Lin Y; Heidt E; Kinney AY
Health Psychol Behav Med; 2022; 10(1):1190-1215. PubMed ID: 36518606
[TBL] [Abstract][Full Text] [Related]
4. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
Kinney AY; Walters ST; Lin Y; Lu SE; Kim A; Ani J; Heidt E; Le Compte CJG; O'Malley D; Stroup A; Paddock LE; Grumet S; Boyce TW; Toppmeyer DL; McDougall JA
J Clin Oncol; 2023 May; 41(15):2767-2778. PubMed ID: 36787512
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.
An J; McDougall J; Lin Y; Lu SE; Walters ST; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38490263
[TBL] [Abstract][Full Text] [Related]
6. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
[TBL] [Abstract][Full Text] [Related]
8. Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.
Gómez-Trillos S; Graves KD; Fiallos K; Schwartz MD; Peshkin BN; Hamilton H; Sheppard VB; Vadaparampil ST; Campos C; Cupertino AP; Alzamora MC; Lynce F; Hurtado-de-Mendoza A
Transl Behav Med; 2023 May; 13(5):297-308. PubMed ID: 36694918
[TBL] [Abstract][Full Text] [Related]
9. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
10. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract][Full Text] [Related]
11. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.
Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD
Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089
[TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.
Williams CD; Bullard AJ; O'Leary M; Thomas R; Redding TS; Goldstein K
J Racial Ethn Health Disparities; 2019 Jun; 6(3):570-583. PubMed ID: 30963508
[TBL] [Abstract][Full Text] [Related]
13. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
14. Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods.
Sheppard VB; Sutton AL; Hurtado-De-Mendoza A; Tariq F; Perera RA; Quillin J; Jeudy M; Gómez-Trillos S; Schwartz MD
Contemp Clin Trials; 2023 Jul; 130():107210. PubMed ID: 37142159
[TBL] [Abstract][Full Text] [Related]
15. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
Bellcross CA
Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
[TBL] [Abstract][Full Text] [Related]
16. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract][Full Text] [Related]
17. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
Werner-Lin A; Ratner R; Hoskins LM; Lieber C
J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
[TBL] [Abstract][Full Text] [Related]
18. Translating research into practice: Protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative.
Battaglia TA; Freund KM; Haas JS; Casanova N; Bak S; Cabral H; Freedman RA; White KB; Lemon SC;
Contemp Clin Trials; 2020 Jun; 93():106007. PubMed ID: 32305457
[TBL] [Abstract][Full Text] [Related]
19. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
20. A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.
Conley CC; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Burgos C; Ricker C; Kim J; Graves KD; Ashing KT; Quinn GP; Soliman H; Vadaparampil ST
J Genet Couns; 2021 Apr; 30(2):394-405. PubMed ID: 32936981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
